Thinking beyond HbA1c in type 2 diabetes - Tackling Cardiovascular Morbidity and Mortality – A focus on SGLT2 Inhibitors
The UKCPA/JOMO study day has become the main event in the respiratory pharmacy calendar. Despite the challenges this year this speakers and sessions were excellent.
NHS attendee at the UKCPA/JOMO respiratory study day
|Satellite||Thinking beyond HbA1c in type 2 diabetes - Tackling Cardiovascular Morbidity and Mortality – A focus on SGLT2 Inhibitors|
|Speakers||Dr Rani Khatib, Consultant Pharmacist in Cardiology and Cardiovascular Research, Leeds Teaching Hospitals NHS Trust|
This session has been sponsored, including speaker honoraria and presentation development support, by the Boehringer Ingelheim and Lilly Diabetes Alliance
PC-GB-100225 September 2019